These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Classification of the external auditory canal cholesteatoma. Naim R; Linthicum F; Shen T; Bran G; Hormann K Laryngoscope; 2005 Mar; 115(3):455-60. PubMed ID: 15744157 [TBL] [Abstract][Full Text] [Related]
9. External auditory canal cholesteatoma: reassessment of and amendments to its categorization, pathogenesis, and treatment in 34 patients. Dubach P; Häusler R Otol Neurotol; 2008 Oct; 29(7):941-8. PubMed ID: 18758389 [TBL] [Abstract][Full Text] [Related]
11. Sulindac sulfone modulates beta-catenin in human cholesteatoma cell culture. Sauter A; Matharu R; Braun T; Schultz J; Sadick H; Hormann K; Naim R Arch Med Res; 2007 May; 38(4):367-71. PubMed ID: 17416281 [TBL] [Abstract][Full Text] [Related]
12. Co-expression of different angiogenic factors in external auditory canal cholesteatoma. Naim R; Riedel F; Gotte K; Bran G; Sadick H; Gossler U; Hormann K Acta Otolaryngol; 2004 Jun; 124(5):563-8. PubMed ID: 15267172 [TBL] [Abstract][Full Text] [Related]
13. Gelatinolytic activity of matrix metalloproteinases 2 and 9 in middle ear cholesteatoma. Suchozebrska-Jesionek D; Szymański M; Kurzepa J; Gołabek W; Stryjecka-Zimmer M J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):628-32. PubMed ID: 19128667 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959 [TBL] [Abstract][Full Text] [Related]
15. Regulation of apoptosis in external auditory canal cholesteatoma by hepatocyte growth factor/scatter factor. Naim R; Shen T; Riedel F; Bran G; Sadick H; Hormann K ORL J Otorhinolaryngol Relat Spec; 2005; 67(1):45-50. PubMed ID: 15753622 [TBL] [Abstract][Full Text] [Related]
16. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375 [TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin, beta-catenin, cathepsin D, gelatinases and their inhibitors in invasive ductal breast carcinomas. Zhang YG; DU J; Tian XX; Zhong YF; Fang WG Chin Med J (Engl); 2007 Sep; 120(18):1597-605. PubMed ID: 17908479 [TBL] [Abstract][Full Text] [Related]
18. Effect of vascular endothelial growth factor on fibroblasts from external auditory canal cholesteatoma. Naim R; Chang RC; Sadick H; Bayerl C; Bran G; Hormann K Arch Med Res; 2005; 36(5):518-23. PubMed ID: 16099332 [TBL] [Abstract][Full Text] [Related]
19. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Rodríguez-Sastre MA; González-Maya L; Delgado R; Lizano M; Tsubaki G; Mohar A; García-Carrancá A Gynecol Oncol; 2005 May; 97(2):330-6. PubMed ID: 15863126 [TBL] [Abstract][Full Text] [Related]
20. Primary cholesteatoma of the external auditory canal: is the epithelial migration defective? Bonding P; Ravn T Otol Neurotol; 2008 Apr; 29(3):334-8. PubMed ID: 18277309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]